Microbot Medical Stock In The News

MBOT Stock  USD 1.99  0.17  7.87%   
Our overall analysis of Microbot Medical's news coverage and content from conventional and social sources shows investors' bearish mood towards Microbot Medical. The specific impact of Microbot Medical news on its stock price will depend on a range of factors, including the nature and significance of the news report and investors' perceptions of Microbot Medical's overall financial health and prospects. It also depends on the type and quality of a news publisher.
  
Some academic researchers believe in a strong correlation between financial news and their impacts on the movements of stock prices. Macroaxis does not take a position on this subject and only provides tools that can help investors to time the market using Microbot Medical headlines in addition to utilizing other, more conventional financial analysis modules. Check out Microbot Medical Backtesting and Microbot Medical Hype Analysis.
For more information on how to buy Microbot Stock please use our How to Invest in Microbot Medical guide.

Microbot Medical Today Top News and Investor Outlook

Macroaxis News: globenewswire.com
Microbot Medical Closes $13 Million Registered Direct Offering
https://www.globenewswire.com/news-release/2025/02/11/3024659/0/en/Microbot-Medical-Closes-13-Million-Registered-Direct-Offering.html
 Bullish
Macroaxis News: globenewswire.com
Microbot Medical Announces $13 Million Registered Direct Offering Priced At-The-Market under Nasdaq Rules
https://www.globenewswire.com/news-release/2025/02/10/3023367/0/en/Microbot-Medical-Announces-13-Million-Registered-Direct-Offering-Priced-At-The-Market-under-Nasdaq-Rules.html
 Bullish
Yahoo News
3 Stocks at the Forefront of Medical Robotics
https://finance.yahoo.com/news/3-stocks-forefront-medical-robotics-193109973.html
 Bullish
Macroaxis News: globenewswire.com
Microbot Medical Appoints Seasoned Medic...
https://www.globenewswire.com/news-release/2023/11/21/2784122/0/en/Microbot-Medical-Appoints-Seasoned-Medical-Expert-Dr-Juan-Diaz-Cartelle-as-its-New-Chief-Medical-Officer-in-Anticipation-of-Its-Clinical-Regulatory-and-Commercial-Activities.html
 Bullish
Macroaxis News: globenewswire.com
Microbot Medical Successfully Completed Integral Part of the Verification and Validation Process
https://www.globenewswire.com/news-release/2023/11/13/2779069/0/en/Microbot-Medical-Successfully-Completed-Integral-Part-of-the-Verification-and-Validation-Process.html
 Bullish
Macroaxis News: globenewswire.com
Microbot Medical Granted Registered Trademark from The U.S. Patent and Trademark Office
https://www.globenewswire.com/news-release/2023/11/08/2776370/0/en/Microbot-Medical-Granted-Registered-Trademark-from-The-U-S-Patent-and-Trademark-Office.html
 Neutral
Macroaxis News: globenewswire.com
Microbot Medical Reveals Successful Short Term Follow Up Outcomes from its Pivotal Pre-Clinical Study
https://www.globenewswire.com/news-release/2023/10/31/2770166/0/en/Microbot-Medical-Reveals-Successful-Short-Term-Follow-Up-Outcomes-from-its-Pivotal-Pre-Clinical-Study.html
 Bullish
Macroaxis News: globenewswire.com
Microbot Medical Received Confirmation for the Commencement of Its CE Mark Approval Process During the First Half of 2024
https://www.globenewswire.com/news-release/2023/10/24/2765610/0/en/Microbot-Medical-Received-Confirmation-for-the-Commencement-of-Its-CE-Mark-Approval-Process-During-the-First-Half-of-2024.html
 Bullish
Macroaxis News: globenewswire.com
Microbot Medical Announces Grant of Summary Judgment in its Favor and Dismissal of Counterclaim Against Company
https://www.globenewswire.com/news-release/2023/10/19/2763173/0/en/Microbot-Medical-Announces-Grant-of-Summary-Judgment-in-its-Favor-and-Dismissal-of-Counterclaim-Against-Company.html
 Neutral
Macroaxis News: globenewswire.com
Microbot Medical Announces Successful Initial Outcomes from Its Pivotal Pre-Clinical Study with the LIBERTY® Robotic Surgical System
https://www.globenewswire.com/news-release/2023/10/17/2761629/0/en/Microbot-Medical-Announces-Successful-Initial-Outcomes-from-Its-Pivotal-Pre-Clinical-Study-with-the-LIBERTY-Robotic-Surgical-System.html
 Bullish

Microbot Medical Past News Timeline

Popular news outlets such as MarketWatch, Bloomberg, or Reuters provide Microbot and other traded companies coverage with news coverage. We help investors stay connected with Microbot headlines for the 17th of February 2025 to make an informed investment decision based on correlating the impacts of news items on Microbot Stock performance. Please note that trading solely based on the Microbot Medical hype is not for everyone as timely availability and quick action are needed to avoid losses.
Microbot Medical's linear event process diagram shows some of the filtered current and past headlines as well as many other corporate-specific events such as SEC filings, dividends, and regulatory reporting available to the public. This module can help Microbot Medical investors visualize upcoming and past events in order to time the market based on Microbot Medical noise-free hype analysis.
Microbot Medical stock price changes are notoriously difficult to predict based exclusively on its news coverage or social hype. Still, the Microbot earnings-per-share ratio is a good starting point for gauging a company's future prospects. If a firm's EPS rises and meets or even beats consensus forecasts, its shares stand to increase. However, some very sophisticated investors can spot management manipulation of EPS through actions such as buybacks.
Far too much social signal, news, headlines, and media speculation about Microbot Medical that are available to investors today. That information is available publicly through Microbot media outlets and privately through word of mouth or via Microbot internal channels. However, regardless of the origin, that massive amount of Microbot data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Microbot Medical news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Microbot Medical relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Microbot Medical's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Microbot Medical alpha.

Microbot Largest EPS Surprises

Earnings surprises can significantly impact Microbot Medical's stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
Reported
Fiscal Date
Estimated EPS
Reported EPS
Surprise
2018-03-22
2017-12-31-0.04-0.030.0125 
2024-11-12
2024-09-30-0.17-0.2-0.0317 
2020-05-15
2020-03-31-0.28-0.31-0.0310 
2023-11-13
2023-09-30-0.25-0.210.0416 
2019-08-14
2019-06-30-0.41-0.360.0512 
2023-08-14
2023-06-30-0.31-0.250.0619 
View All Earnings Estimates

Microbot Medical Stock Latest Headlines

Some academic researchers believe in a strong correlation between financial news and their impacts on the movements of stock prices. Macroaxis does not take a position on this subject and only provides tools that can help investors to time the market using conventional financial analysis. Below is the latest headlines and news related to Microbot Medical Stock. Current markets are slightly bullish. About 55% of major world exchanges and indexes are currently up. See today's market update for more information.
Gurufocus Stories at Macroaxis
12th of February 2025
Microbot Medical Closes 13 Million Registered Direct Offering
at gurufocus.com 
Macroaxis News: globenewswire.com
10th of February 2025
Microbot Medical Announces 13 Million Registered Direct Offering Priced At-The-Market unde...
at globenewswire.com 
news
5th of February 2025
Microbot Medical Announces Acceptance of Late-Breaking Abstract for SIR Annual MeetingOn F...
at thelincolnianonline.com 
insidermonkey News
4th of February 2025
Why Microbot Medical Inc. Is Skyrocketing So Far In 2025
at insidermonkey.com 
Macroaxis News
22nd of January 2025
Acquisition by Stockburger Aileen Ptucha of 6493 shares of Microbot Medical at 6.16 subjec...
at MacroaxisInsider 
news
21st of January 2025
Microbot Medical Appoints Director of Operations to Strengthen Production Efficiencies
at thelincolnianonline.com 
Macroaxis News: globenewswire.com
10th of January 2025
Microbot Medical Closes 8.6 Million Registered Direct Offering
at globenewswire.com 
news
6th of January 2025
Microbot Medical announces 7M offering to support surgical robot commercialization
at massdevice.com 

Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Microbot Medical in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Microbot Medical's short interest history, or implied volatility extrapolated from Microbot Medical options trading.

Additional Tools for Microbot Stock Analysis

When running Microbot Medical's price analysis, check to measure Microbot Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Microbot Medical is operating at the current time. Most of Microbot Medical's value examination focuses on studying past and present price action to predict the probability of Microbot Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Microbot Medical's price. Additionally, you may evaluate how the addition of Microbot Medical to your portfolios can decrease your overall portfolio volatility.